Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT1A/1B receptor agonist and A2A receptor antagonist
Annalisa Pinna, Giulia Costa, Marcello Serra, Liliana Contu, Micaela Morelli
Topics & Concepts
NeuroinflammationPars compactaSubstantia nigraInternal medicineAgonistEndocrinologyTyrosine hydroxylaseChemistryPharmacologyAdenosine A2A receptorDopamineParkinson's diseaseMedicineReceptorAdenosine receptorDopaminergicInflammationDiseaseAdenosine and Purinergic SignalingNeuroinflammation and Neurodegeneration MechanismsNerve injury and regeneration